2024-01-17 |
2024-01-17 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
12 967
-40.2%
0,67
8 727
USD
|
12 967
-40.2%
|
0,67
|
8 727
USD
|
|
2024-01-17 |
2024-01-17 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
5 309
-40.5%
0,67
3 573
USD
|
5 309
-40.5%
|
0,67
|
3 573
USD
|
|
2024-01-17 |
2024-01-17 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
12 805
-40.2%
0,67
8 618
USD
|
12 805
-40.2%
|
0,67
|
8 618
USD
|
|
2024-01-17 |
2024-01-17 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
5 309
-40.5%
0,67
3 573
USD
|
5 309
-40.5%
|
0,67
|
3 573
USD
|
|
2024-01-17 |
2024-01-17 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
30 080
-40.1%
0,67
20 244
USD
|
30 080
-40.1%
|
0,67
|
20 244
USD
|
|
2024-01-17 |
2024-01-17 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
13 599
-40.2%
0,67
9 152
USD
|
13 599
-40.2%
|
0,67
|
9 152
USD
|
|
2024-01-17 |
2024-01-17 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
5 309
-40.5%
0,67
3 573
USD
|
5 309
-40.5%
|
0,67
|
3 573
USD
|
|
2024-01-17 |
2024-01-16 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
2 287
-40.5%
0,79
1 807
USD
|
2 287
-40.5%
|
0,79
|
1 807
USD
|
|
2024-01-17 |
2024-01-16 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
4 681
-40.0%
0,79
3 698
USD
|
4 681
-40.0%
|
0,79
|
3 698
USD
|
|
2024-01-17 |
2024-01-16 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
9 304
-39.7%
0,79
7 350
USD
|
9 304
-39.7%
|
0,79
|
7 350
USD
|
|
2024-01-17 |
2024-01-16 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
4 681
-40.0%
0,79
3 698
USD
|
4 681
-40.0%
|
0,79
|
3 698
USD
|
|
2024-01-12 |
2024-01-12 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
5 220
-39.9%
0,85
4 458
USD
|
5 220
-39.9%
|
0,85
|
4 458
USD
|
|
2024-01-12 |
2024-01-12 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
7 799
-39.7%
0,85
6 661
USD
|
7 799
-39.7%
|
0,85
|
6 661
USD
|
|
2024-01-12 |
2024-01-12 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
17 257
-39.5%
0,85
14 739
USD
|
17 257
-39.5%
|
0,85
|
14 739
USD
|
|
2024-01-12 |
2024-01-12 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
5 220
-39.9%
0,85
4 458
USD
|
5 220
-39.9%
|
0,85
|
4 458
USD
|
|
2024-01-12 |
2024-01-11 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
4 009
-39.6%
0,84
3 354
USD
|
4 009
-39.6%
|
0,84
|
3 354
USD
|
|
2024-01-12 |
2024-01-11 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
4 009
-39.6%
0,84
3 354
USD
|
4 009
-39.6%
|
0,84
|
3 354
USD
|
|
2024-01-12 |
2024-01-11 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
11 945
-39.4%
0,84
9 994
USD
|
11 945
-39.4%
|
0,84
|
9 994
USD
|
|
2024-01-12 |
2024-01-11 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
4 009
-39.6%
0,84
3 354
USD
|
4 009
-39.6%
|
0,84
|
3 354
USD
|
|
2023-09-01 |
2023-09-01 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
2 403
-41.1%
0,78
1 874
USD
|
2 403
-41.1%
|
0,78
|
1 874
USD
|
|
2023-08-01 |
2023-08-01 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
3 096
-39.6%
0,91
2 804
USD
|
3 096
-39.6%
|
0,91
|
2 804
USD
|
|
2023-07-10 |
2023-07-10 |
V
Vente
|
Menzel Garry E
Administrateur non-exécutif
|
47 702
-38.9%
0,91
43 447
USD
|
47 702
-38.9%
|
0,91
|
43 447
USD
|
|
2023-06-27 |
2023-06-27 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
2 333
-39.9%
0,92
2 146
USD
|
2 333
-39.9%
|
0,92
|
2 146
USD
|
|
2023-01-31 |
2023-01-31 |
V
Vente
|
Piccina Cintia
Chief Commercial Officer
Dirigeant
|
11 890
-37.8%
1,87
22 230
USD
|
11 890
-37.8%
|
1,87
|
22 230
USD
|
|
2023-01-17 |
2023-01-17 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
2 159
-38.2%
1,86
4 011
USD
|
2 159
-38.2%
|
1,86
|
4 011
USD
|
|
2023-01-17 |
2023-01-17 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
4 440
-37.9%
1,86
8 250
USD
|
4 440
-37.9%
|
1,86
|
8 250
USD
|
|
2023-01-17 |
2023-01-17 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
4 440
-37.9%
1,86
8 250
USD
|
4 440
-37.9%
|
1,86
|
8 250
USD
|
|
2023-01-17 |
2023-01-17 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
10 057
-43.0%
1,86
18 686
USD
|
10 057
-43.0%
|
1,86
|
18 686
USD
|
|
2023-01-12 |
2023-01-12 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
7 449
-37.9%
1,71
12 708
USD
|
7 449
-37.9%
|
1,71
|
12 708
USD
|
|
2023-01-12 |
2023-01-12 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
4 973
-38.0%
1,71
8 484
USD
|
4 973
-38.0%
|
1,71
|
8 484
USD
|
|
2023-01-12 |
2023-01-12 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
4 973
-38.0%
1,71
8 484
USD
|
4 973
-38.0%
|
1,71
|
8 484
USD
|
|
2023-01-12 |
2023-01-12 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
18 763
-43.0%
1,71
32 010
USD
|
18 763
-43.0%
|
1,71
|
32 010
USD
|
|
2023-01-12 |
2023-01-11 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
3 843
-38.0%
1,75
6 713
USD
|
3 843
-38.0%
|
1,75
|
6 713
USD
|
|
2023-01-12 |
2023-01-11 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
3 843
-38.0%
1,75
6 713
USD
|
3 843
-38.0%
|
1,75
|
6 713
USD
|
|
2023-01-12 |
2023-01-11 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
3 843
-38.0%
1,75
6 713
USD
|
3 843
-38.0%
|
1,75
|
6 713
USD
|
|
2023-01-12 |
2023-01-11 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
13 042
-43.0%
1,75
22 782
USD
|
13 042
-43.0%
|
1,75
|
22 782
USD
|
|
2023-01-04 |
2023-01-04 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
5 073
-43.3%
1,69
8 594
USD
|
5 073
-43.3%
|
1,69
|
8 594
USD
|
|
2023-01-04 |
2023-01-04 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
1 100
-38.9%
1,69
1 863
USD
|
1 100
-38.9%
|
1,69
|
1 863
USD
|
|
2023-01-04 |
2023-01-04 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
3 584
-38.3%
1,69
6 071
USD
|
3 584
-38.3%
|
1,69
|
6 071
USD
|
|
2023-01-04 |
2023-01-04 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
876
-39.2%
1,69
1 484
USD
|
876
-39.2%
|
1,69
|
1 484
USD
|
|
2022-09-01 |
2022-09-01 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
2 536
-43.3%
1,97
4 993
USD
|
2 536
-43.3%
|
1,97
|
4 993
USD
|
|
2022-08-01 |
2022-08-01 |
V
Vente
|
Piccina Cintia
Chief Commercial Officer
Dirigeant
|
21 040
-37.7%
1,77
37 314
USD
|
21 040
-37.7%
|
1,77
|
37 314
USD
|
|
2022-08-01 |
2022-08-01 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
2 983
-38.2%
1,77
5 290
USD
|
2 983
-38.2%
|
1,77
|
5 290
USD
|
|
2022-07-05 |
2022-07-05 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
1 973
-38.9%
1,68
3 311
USD
|
1 973
-38.9%
|
1,68
|
3 311
USD
|
|
2022-06-27 |
2022-06-27 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
2 562
-43.8%
1,63
4 176
USD
|
2 562
-43.8%
|
1,63
|
4 176
USD
|
|
2022-05-23 |
2022-05-20 |
A
Achat
|
Wood Gavin
Chief Financial Officer
Dirigeant
|
39 000
+68.4%
0,29
11 326
USD
|
39 000
+68.4%
|
0,29
|
11 326
USD
|
|
2022-01-18 |
2022-01-18 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
2 121
-37.5%
3,19
6 770
USD
|
2 121
-37.5%
|
3,19
|
6 770
USD
|
|
2022-01-18 |
2022-01-18 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
11 096
-47.4%
3,19
35 416
USD
|
11 096
-47.4%
|
3,19
|
35 416
USD
|
|
2022-01-18 |
2022-01-18 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
4 368
-37.3%
3,19
13 942
USD
|
4 368
-37.3%
|
3,19
|
13 942
USD
|
|
2022-01-18 |
2022-01-18 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
4 368
-37.3%
3,19
13 942
USD
|
4 368
-37.3%
|
3,19
|
13 942
USD
|
|
2022-01-13 |
2022-01-12 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
1 076
-38.1%
3,54
3 813
USD
|
1 076
-38.1%
|
3,54
|
3 813
USD
|
|
2022-01-13 |
2022-01-12 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
3 046
-47.6%
3,54
10 795
USD
|
3 046
-47.6%
|
3,54
|
10 795
USD
|
|
2022-01-13 |
2022-01-12 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
2 248
-37.5%
3,54
7 967
USD
|
2 248
-37.5%
|
3,54
|
7 967
USD
|
|
2022-01-13 |
2022-01-12 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
854
-38.2%
3,54
3 027
USD
|
854
-38.2%
|
3,54
|
3 027
USD
|
|
2022-01-13 |
2022-01-11 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
3 770
-37.3%
3,56
13 409
USD
|
3 770
-37.3%
|
3,56
|
13 409
USD
|
|
2022-01-13 |
2022-01-11 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
14 362
-47.3%
3,56
51 081
USD
|
14 362
-47.3%
|
3,56
|
51 081
USD
|
|
2022-01-13 |
2022-01-11 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
3 770
-37.3%
3,56
13 409
USD
|
3 770
-37.3%
|
3,56
|
13 409
USD
|
|
2022-01-13 |
2022-01-11 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
3 770
-37.3%
3,56
13 409
USD
|
3 770
-37.3%
|
3,56
|
13 409
USD
|
|
2022-01-05 |
2022-01-04 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
1 070
-37.9%
4,06
4 349
USD
|
1 070
-37.9%
|
4,06
|
4 349
USD
|
|
2022-01-05 |
2022-01-04 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
3 490
-37.3%
4,06
14 184
USD
|
3 490
-37.3%
|
4,06
|
14 184
USD
|
|
2022-01-05 |
2022-01-04 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
5 532
-47.3%
4,06
22 483
USD
|
5 532
-47.3%
|
4,06
|
22 483
USD
|
|
2022-01-05 |
2022-01-04 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
849
-38.0%
4,06
3 451
USD
|
849
-38.0%
|
4,06
|
3 451
USD
|
|
2021-06-28 |
2021-06-28 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
2 794
-47.7%
4,37
12 210
USD
|
2 794
-47.7%
|
4,37
|
12 210
USD
|
|
2021-01-19 |
2021-01-19 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
2 111
-37.4%
5,67
11 968
USD
|
2 111
-37.4%
|
5,67
|
11 968
USD
|
|
2021-01-19 |
2021-01-19 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
4 358
-37.2%
5,67
24 708
USD
|
4 358
-37.2%
|
5,67
|
24 708
USD
|
|
2021-01-19 |
2021-01-19 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
9 879
-42.2%
5,67
56 009
USD
|
9 879
-42.2%
|
5,67
|
56 009
USD
|
|
2021-01-12 |
2021-01-12 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
841
-37.6%
6,15
5 174
USD
|
841
-37.6%
|
6,15
|
5 174
USD
|
|
2021-01-12 |
2021-01-12 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
2 234
-37.2%
6,15
13 744
USD
|
2 234
-37.2%
|
6,15
|
13 744
USD
|
|
2021-01-12 |
2021-01-12 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
1 058
-37.5%
6,15
6 509
USD
|
1 058
-37.5%
|
6,15
|
6 509
USD
|
|
2021-01-12 |
2021-01-12 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
2 707
-42.3%
6,15
16 654
USD
|
2 707
-42.3%
|
6,15
|
16 654
USD
|
|
2021-01-05 |
2021-01-04 |
V
Vente
|
Lunger John
Chief Patient Supply Officer
Dirigeant
|
1 065
-37.7%
5,33
5 674
USD
|
1 065
-37.7%
|
5,33
|
5 674
USD
|
|
2021-01-05 |
2021-01-04 |
V
Vente
|
Norry Elliot
Chief Medical Officer
Dirigeant
|
845
-37.8%
5,33
4 502
USD
|
845
-37.8%
|
5,33
|
4 502
USD
|
|
2021-01-05 |
2021-01-04 |
V
Vente
|
Rawcliffe Adrian
Chief Executive Officer
Administrateur exécutif
|
4 967
-42.4%
5,33
26 464
USD
|
4 967
-42.4%
|
5,33
|
26 464
USD
|
|
2021-01-05 |
2021-01-04 |
V
Vente
|
Bertrand William C JR
Chief Operating Officer
Dirigeant
|
3 499
-37.4%
5,33
18 642
USD
|
3 499
-37.4%
|
5,33
|
18 642
USD
|
|
2020-12-16 |
2020-12-14 |
A
Achat
|
Wood Gavin
Chief Financial Officer
Dirigeant
|
24 000
+72.7%
0,69
16 550
USD
|
24 000
+72.7%
|
0,69
|
16 550
USD
|
|